Seger Surgical Solutions

Company Overview

Snapshot

Founded in December 2016 by Leo R. Mindick and Prof. Barry Salky, Seger Surgical Solutions operates with 1-10 employees. The company has secured funding across one round from two investors, The Trendlines Group and Israel Innovation Authority. In March 2026, the company announced the successful completion of human trials for its laparoscopic bowel-closure device.

Business overview

Seger Surgical Solutions develops medical devices for minimally invasive surgery, focusing on improving laparoscopic procedures. Its core product, LAP IA 60, is a laparoscopic bowel-closure device designed for quick and secure alignment, closure, and stapling during intracorporeal anastomosis, eliminating the need for suturing. The device integrates with standard 12-millimeter trocars, aiming to enhance clinical outcomes, reduce complications, and lower healthcare costs. The company primarily serves the healthcare industry, specifically providers, within the Health Tech & Life Sciences sector, with a focus on Medical Devices and Medical Treatment & Therapeutics.

Strategic signal

In March 2026, Seger Surgical Solutions announced the successful completion of human trials for its LAP IA 60 laparoscopic bowel-closure device. This milestone is a critical validation of the device's efficacy and safety, signaling to investors and the medical community that the company is progressing towards commercialization and addressing a significant need in minimally invasive surgical procedures.

Company Intelligence Q&A

When was Seger Surgical Solutions founded?

Seger Surgical Solutions was founded in December 2016.

What is Seger Surgical Solutions' primary product?

Seger Surgical Solutions' primary product is LAP IA 60, a laparoscopic bowel-closure device designed for intracorporeal anastomosis.

What significant development did Seger Surgical Solutions announce in March 2026?

In March 2026, Seger Surgical Solutions announced the successful completion of human trials for its laparoscopic bowel-closure device.

Which investors have participated in Seger Surgical Solutions' funding rounds?

Seger Surgical Solutions has received funding from The Trendlines Group and Israel Innovation Authority.

What was a key strategic collaboration for Seger Surgical Solutions in January 2022?

In January 2022, Seger Surgical Solutions announced a collaboration with Waston Medical, a Chinese medical device company, for human trials and FDA clearance of its laparoscopic stapler.